NIH launches large TB prevention trial for people exposed to multidrug-resistant TB

A large clinical trial to assess treatments for preventing people at high risk from developing multidrug-resistant tuberculosis (MDR-TB) has begun. The study is comparing the safety and efficacy of a new MDR-TB drug, delamanid, with the decades-old TB drug isoniazid for preventing active MDR-TB disease in children, adolescents and adults at high risk who are exposed to adult household members […]

Continue reading »

Millions with high blood sugar face TB risk

Millions of people with high blood sugar may be at greater risk of tuberculosis than previously thought, scientists said Friday, warning that diabetes and TB could combine to create the “perfect storm” of disease. Tuberculosis, a severe infection caused by bacteria in the lungs, kills almost as many people each year as HIV/AIDS and malaria combined. In 2017 nearly 10 […]

Continue reading »

New drug slashes death rates among drug-resistant TB patients: scientists

Credit: CC0 Public Domain A new treatment for a deadly drug-resistant strain of tuberculosis can cure more than 90 percent of sufferers, according to a landmark clinical trial whose results were revealed exclusively to AFP. Doctors in Belarus—a country with one of the world’s highest rates of multidrug-resistant tuberculosis—treated 181 patients with the new drug, bedaquiline, in combination with other […]

Continue reading »